endometrial cancer
FDA Expands Endometrial Cancer Indication for Jemperli With Chemotherapy
The FDA has approved dostarlimab-gxly (Jemperli, GSK) with carboplatin and paclitaxel, followed by single-agent ...
AUGUST 1, 2024
FDA Approves Keytruda With Chemo for Primary Advanced or Recurrent Endometrial Carcinoma
The FDA has approved pembrolizumab (Keytruda, Merck) with carboplatin and paclitaxel, followed by single-agent ...
JUNE 18, 2024
FDA Approves Imfinzi With Chemo for dMMR Primary Advanced or Recurrent Endometrial Cancer
The FDA has approved durvalumab (Imfinzi, AstraZeneca UK Limited) with carboplatin plus paclitaxel followed by ...
JUNE 17, 2024
Gynecologic Cancer Misinformation Prevalent on TikTok
Gynecologic cancer–related content on the TikTok social media platform is of poor educational quality, and ...
OCTOBER 6, 2023
FDA Approves Jemperli With Chemotherapy for Endometrial Cancer
The FDA approved dostarlimab-gxly (Jemperli, GlaxoSmithKline) with carboplatin and paclitaxel, followed by ...
AUGUST 2, 2023
Trastuzumab Deruxtecan Demonstrates Benefit Across an Array of HER2-Expressing Tumors
The antibody–drug conjugate trastuzumab deruxtecan (T-DXd) (Enhertu, Daiichi Sankyo/AstraZeneca) is emerging ...
JULY 7, 2023
Combined Dostarlimab, Standard of Care Improves Survival for Endometrial Cancer Patients
Adding the programmed cell death protein-1 (PD-1) checkpoint inhibitor dostarlimab (Jemperli, GSK) to carboplatin ...
MAY 3, 2023
Jemperli Gets Full Approval for Endometrial Cancer
The FDA approved dostarlimab-gxly (Jemperli, GlaxoSmithKline) for adult patients with mismatch repair-deficient ...
FEBRUARY 13, 2023
Pembrolizumab Newly Indicated to Treat Advanced Endometrial Carcinoma
The FDA approved pembrolizumab (Keytruda, Merck) for the treatment of patients with microsatellite instability?high ...
MARCH 23, 2022
New PD-1 Jemperli Approved to Treat Mismatch Repair–Deficient Endometrial Cancer
The FDA granted accelerated approval to the programmed death receptor-1-blocking antibody dostarlimab-gxly ...
MAY 4, 2021
Case Report: Molecular Detection of Endometrial Precancer Using a Targeted Gynecologic Cancer Liquid Biopsy
This case study shows that uterine fluid may provide a sensitive and specific diagnostic test for the molecular ...
MAY 17, 2019
Endometrial Ca: Sx Too Early Can Raise Mortality Risk
It may come as no surprise that delaying hysterectomy in women with endometrial cancer can increase their risk for ...
APRIL 5, 2017
